Healthpeak Properties, Inc. (NYSE:DOC) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Healthpeak Properties, Inc. (NYSE:DOCGet Free Report) have been given an average recommendation of “Moderate Buy” by the twelve brokerages that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $20.8182.

A number of analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $18.00 price objective (down from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Morgan Stanley dropped their price target on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a research report on Friday, August 22nd. Robert W. Baird reduced their price target on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research note on Wednesday. Raymond James Financial raised shares of Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research report on Monday, September 15th. Finally, Scotiabank downgraded shares of Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and dropped their target price for the company from $21.00 to $19.00 in a report on Tuesday, July 29th.

Get Our Latest Research Report on DOC

Hedge Funds Weigh In On Healthpeak Properties

A number of hedge funds and other institutional investors have recently bought and sold shares of DOC. State Street Corp lifted its position in shares of Healthpeak Properties by 0.9% during the second quarter. State Street Corp now owns 48,602,649 shares of the real estate investment trust’s stock worth $851,032,000 after purchasing an additional 442,481 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Healthpeak Properties by 41.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock worth $540,730,000 after buying an additional 8,212,504 shares during the period. Invesco Ltd. lifted its holdings in Healthpeak Properties by 20.7% during the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock worth $467,311,000 after buying an additional 3,967,830 shares in the last quarter. Geode Capital Management LLC boosted its position in Healthpeak Properties by 1.0% in the 2nd quarter. Geode Capital Management LLC now owns 19,071,094 shares of the real estate investment trust’s stock valued at $332,625,000 after buying an additional 197,540 shares during the period. Finally, Fuller & Thaler Asset Management Inc. grew its stake in shares of Healthpeak Properties by 6.5% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 18,397,841 shares of the real estate investment trust’s stock worth $372,004,000 after acquiring an additional 1,129,924 shares in the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Down 0.9%

DOC stock opened at $17.49 on Friday. Healthpeak Properties has a one year low of $16.63 and a one year high of $22.71. The firm has a market cap of $12.15 billion, a PE ratio of -349.63, a PEG ratio of 3.84 and a beta of 1.10. The firm’s 50 day moving average price is $18.37 and its 200-day moving average price is $17.84. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.28 and a current ratio of 1.22.

Healthpeak Properties (NYSE:DOCGet Free Report) last posted its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.01. Healthpeak Properties had a negative return on equity of 0.44% and a negative net margin of 1.36%.The company had revenue of $705.87 million during the quarter, compared to analysts’ expectations of $681.65 million. During the same quarter last year, the firm earned $0.45 earnings per share. The firm’s quarterly revenue was up .8% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, equities research analysts anticipate that Healthpeak Properties will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be issued a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 7.0%. The ex-dividend date is Friday, December 19th. Healthpeak Properties’s payout ratio is currently -2,440.00%.

Healthpeak Properties Company Profile

(Get Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Featured Articles

Analyst Recommendations for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.